• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征及其组分对血液透析期间心率变异性的影响:一项横断面研究。

Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study.

作者信息

Chang Yu-Ming, Shiao Chih-Chung, Huang Ya-Ting, Chen I-Ling, Yang Chuan-Lan, Leu Show-Chin, Su Hung-Li, Kao Jsun-Liang, Tsai Shih-Ching, Jhen Rong-Na, Uen Ching-Cherng

机构信息

Division of Nephrology, Department of Internal Medicine, Saint Mary's Hospital Luodong, No. 160 Chong-Cheng South Road, Loudong, 265, Yilan, Taiwan, ROC.

Saint Mary's Medicine, Nursing and Management College, No. 100, Ln. 265, Sec. 2, Sanxing Rd., Sanxing Township, Yilan County, 266, Taiwan, ROC.

出版信息

Cardiovasc Diabetol. 2016 Jan 27;15:16. doi: 10.1186/s12933-016-0328-2.

DOI:10.1186/s12933-016-0328-2
PMID:26817599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4729144/
Abstract

BACKGROUND

Both uremia and metabolic syndrome (MetS) affect heart rate variability (HRV) which is a risk factor of poor prognoses. The aim of this study was to evaluate the impact of MetS on HRV among chronic hemodialysis patients.

METHODS

This cross-sectional study was carried out in a teaching hospital in Northern Taiwan from June to August, 2010. Adult patients on chronic hemodialysis without active medical conditions were enrolled. HRV were measured for 4 times on the index hemodialysis day (HRV-0, -1, -2, and -3 at before, initial, middle, and late phases of hemodialysis, respectively), and the baseline demographic data and clinical parameters during the hemodialysis session were documented. Then we evaluated the impacts of MetS and its five components on HRV.

RESULTS

One hundred and seventy-five patients (100 women, mean age 65.1 ± 12.9 years) were enrolled and included those with MetS (n = 91, 52 %) and without MetS (n = 84, 48 %). The patients with MetS(+) had significantly lower very low frequency, total power, and variance in HRV-0, total power and variance in HRV-2, and variance in HRV-3. (all p ≦ 0.05) When using the individual components of MetS to evaluate the impacts on HRV indices, the fasting plasma glucose (FPG) criterion significantly affected most indices of HRV while other four components including "waist circumference", "triglycerides", "blood pressure", and "high-density lipoprotein" criteria exhibited little impacts on HRV. FPG criterion carried the most powerful influence on cardiac ANS, which was even higher than that of MetS. The HRV of patients with FPG(+) increased initially during the hemodialysis, but turned to decrease dramatically at the late phase of hemodialysis.

CONCLUSIONS

The impact of FPG(+) outstood the influence of uremic autonomic dysfunction, and FPG criterion was the most important one among all the components of MetS to influence HRV. These results underscored the importance of interpretation and management for abnormal glucose metabolism.

摘要

背景

尿毒症和代谢综合征(MetS)均会影响心率变异性(HRV),而心率变异性是预后不良的一个危险因素。本研究旨在评估MetS对慢性血液透析患者心率变异性的影响。

方法

本横断面研究于2010年6月至8月在台湾北部的一家教学医院开展。纳入无活动性疾病的成年慢性血液透析患者。在透析当日对心率变异性进行4次测量(分别在血液透析前、开始时、中间和后期的HRV-0、-1、-2和-3),并记录血液透析期间的基线人口统计学数据和临床参数。然后我们评估了MetS及其五个组分对心率变异性的影响。

结果

共纳入175例患者(100名女性,平均年龄65.1±12.9岁),包括患有MetS的患者(n = 91,52%)和未患有MetS的患者(n = 84,48%)。患有MetS(+)的患者在HRV-0中的极低频、总功率和方差显著更低,在HRV-2中的总功率和方差以及在HRV-3中的方差也显著更低。(所有p≤0.05)当使用MetS各组分评估对心率变异性指标的影响时,空腹血糖(FPG)标准显著影响大多数心率变异性指标,而其他四个组分包括“腰围”、“甘油三酯”、“血压”和“高密度脂蛋白”标准对心率变异性影响甚微。FPG标准对心脏自主神经系统的影响最为显著,甚至高于MetS。FPG(+)患者的心率变异性在血液透析开始时最初升高,但在血液透析后期急剧下降。

结论

空腹血糖升高(FPG+)的影响超过尿毒症自主神经功能障碍的影响,并且FPG标准是MetS所有组分中影响心率变异性最重要的因素。这些结果强调了对异常糖代谢进行解读和管理的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f19/4729144/e6e79920f43f/12933_2016_328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f19/4729144/e6e79920f43f/12933_2016_328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f19/4729144/e6e79920f43f/12933_2016_328_Fig1_HTML.jpg

相似文献

1
Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study.代谢综合征及其组分对血液透析期间心率变异性的影响:一项横断面研究。
Cardiovasc Diabetol. 2016 Jan 27;15:16. doi: 10.1186/s12933-016-0328-2.
2
Associations between heart rate variability, metabolic syndrome risk factors, and insulin resistance.心率变异性、代谢综合征风险因素与胰岛素抵抗之间的关联。
Appl Physiol Nutr Metab. 2015 Jul;40(7):734-40. doi: 10.1139/apnm-2014-0528.
3
Associations among integrated psychoneuroimmunological factors and metabolic syndrome.综合心理神经免疫学因素与代谢综合征之间的关联。
Psychoneuroendocrinology. 2016 Dec;74:342-349. doi: 10.1016/j.psyneuen.2016.09.027. Epub 2016 Oct 7.
4
The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.心率及心率变异性与非糖尿病空腹血糖水平和代谢综合征的关系:心血管健康研究
Diabet Med. 2007 Aug;24(8):855-63. doi: 10.1111/j.1464-5491.2007.02163.x. Epub 2007 Apr 2.
5
Metabolic syndrome and short-term heart rate variability in adults with intellectual disabilities.代谢综合征与成年智力障碍者短期心率变异性。
Res Dev Disabil. 2012 Nov-Dec;33(6):1701-7. doi: 10.1016/j.ridd.2012.04.005. Epub 2012 Jun 7.
6
Women with metabolic syndrome present different autonomic modulation and blood pressure response to an acute resistance exercise session compared with women without metabolic syndrome.与无代谢综合征的女性相比,患有代谢综合征的女性在急性抗阻训练期间表现出不同的自主神经调节和血压反应。
Clin Physiol Funct Imaging. 2013 Sep;33(5):364-72. doi: 10.1111/cpf.12038. Epub 2013 Apr 2.
7
Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients.心率变异性是慢性血液透析患者透析期间低血压的一个指标。
Clin Exp Nephrol. 2016 Aug;20(4):650-659. doi: 10.1007/s10157-015-1189-9. Epub 2015 Oct 28.
8
Which is responsible for cardiac autonomic dysfunction in non-diabetic patients with metabolic syndrome: Prediabetes or the syndrome itself?在非糖尿病代谢综合征患者中,是糖尿病前期还是综合征本身导致心脏自主神经功能障碍?
Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S13-20. doi: 10.1016/j.dsx.2015.09.001. Epub 2015 Oct 3.
9
Heart rate variability is associated with glycemic status after controlling for components of the metabolic syndrome.心率变异性与代谢综合征成分得到控制后的血糖状态有关。
Int J Cardiol. 2013 Aug 10;167(3):855-61. doi: 10.1016/j.ijcard.2012.02.002. Epub 2012 Mar 3.
10
Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.非糖尿病中老年人群中空腹胰岛素水平与代谢综合征的关系:一项基于社区的台湾研究。
BMJ Open. 2018 May 3;8(5):e016554. doi: 10.1136/bmjopen-2017-016554.

引用本文的文献

1
The Clinical Significance and Application of Heart Rate Variability in Dialysis Patients: A Narrative Review.心率变异性在透析患者中的临床意义及应用:一项叙述性综述
Biomedicines. 2024 Jul 11;12(7):1547. doi: 10.3390/biomedicines12071547.
2
Low-Frequency/High-Frequency Ratio Is a Predictor of Death and Hospitalization in Patients on Maintenance Hemodialysis: A Prospective Study.低频/高频比值是维持性血液透析患者死亡和住院的预测指标:一项前瞻性研究。
Blood Purif. 2024;53(7):557-564. doi: 10.1159/000536538. Epub 2024 Feb 7.
3
Short-Term Heart Rate Variability in Metabolic Syndrome: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients.心率变异性是慢性血液透析患者透析期间低血压的一个指标。
Clin Exp Nephrol. 2016 Aug;20(4):650-659. doi: 10.1007/s10157-015-1189-9. Epub 2015 Oct 28.
2
Plasma leptin level is associated with cardiac autonomic dysfunction in patients with type 2 diabetes: HSCAA study.血浆瘦素水平与2型糖尿病患者心脏自主神经功能障碍相关:HSCAA研究。
Cardiovasc Diabetol. 2015 Sep 4;14:117. doi: 10.1186/s12933-015-0280-6.
3
Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality.
代谢综合征中的短期心率变异性:一项系统评价和荟萃分析。
J Clin Med. 2023 Sep 19;12(18):6051. doi: 10.3390/jcm12186051.
4
Reduced heart rate variability is related to the number of metabolic syndrome components and manifest diabetes in the sixth Tromsø study 2007-2008.静息心率变异性降低与第六次特罗姆瑟研究 2007-2008 年的代谢综合征成分数量和显性糖尿病有关。
Sci Rep. 2022 Jul 14;12(1):11998. doi: 10.1038/s41598-022-15824-0.
5
Dynamics of Cardiac Autonomic Responses During Hemodialysis Measured by Heart Rate Variability and Skin Sympathetic Nerve Activity: The Impact of Interdialytic Weight Gain.通过心率变异性和皮肤交感神经活动测量血液透析期间心脏自主神经反应的动态变化:透析间期体重增加的影响
Front Physiol. 2022 May 16;13:890536. doi: 10.3389/fphys.2022.890536. eCollection 2022.
6
Effects of interdialytic interval on heart rate variability in chronic hemodialysis patients: a cross-sectional study.间歇性透析对慢性血液透析患者心率变异性的影响:一项横断面研究。
Sci Rep. 2021 Oct 22;11(1):20944. doi: 10.1038/s41598-021-00093-0.
7
Heart rate variability as an independent predictor for 8-year mortality among chronic hemodialysis patients.心率变异性作为慢性血液透析患者 8 年死亡率的独立预测因子。
Sci Rep. 2020 Jan 21;10(1):881. doi: 10.1038/s41598-020-57792-3.
8
The cut-off values of dietary energy intake for determining metabolic syndrome in hemodialysis patients: A clinical cross-sectional study.膳食能量摄入用于确定血液透析患者代谢综合征的截断值:一项临床横断面研究。
PLoS One. 2018 Mar 14;13(3):e0193742. doi: 10.1371/journal.pone.0193742. eCollection 2018.
9
Erratum to: Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study.《代谢综合征及其组分对血液透析期间心率变异性的影响:一项横断面研究》勘误
Cardiovasc Diabetol. 2017 Jul 14;16(1):90. doi: 10.1186/s12933-017-0562-2.
10
The cardiac effects of carbon nanotubes in rat.碳纳米管对大鼠的心脏影响。
Bioimpacts. 2016;6(2):79-84. doi: 10.15171/bi.2016.11. Epub 2016 Jun 28.
自主神经失衡作为代谢风险、心血管疾病、糖尿病和死亡率的预测指标
J Clin Endocrinol Metab. 2015 Jun;100(6):2443-8. doi: 10.1210/jc.2015-1748.
4
Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance.多囊卵巢综合征中的交感神经激活和内皮功能障碍既不能用肥胖也不能用胰岛素抵抗来解释。
Clin Endocrinol (Oxf). 2015 Dec;83(6):812-9. doi: 10.1111/cen.12803. Epub 2015 May 13.
5
The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: a ten-year follow-up study.2型糖尿病患者异常心率变异性与慢性肾脏病新发之间的关联:一项十年随访研究
Diabetes Res Clin Pract. 2015 Apr;108(1):31-7. doi: 10.1016/j.diabres.2015.01.031. Epub 2015 Jan 23.
6
KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.KDIGO 美国专家组关于 2013 年改善全球肾脏病预后组织(KDIGO)慢性肾脏病血脂管理临床实践指南的解读。
Am J Kidney Dis. 2015 Mar;65(3):354-66. doi: 10.1053/j.ajkd.2014.10.005. Epub 2014 Nov 18.
7
Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients.腹内脂肪指数与维持性血液透析患者心血管事件及死亡风险
Cardiovasc Diabetol. 2014 Oct 4;13:136. doi: 10.1186/s12933-014-0136-5.
8
Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD.5期慢性肾脏病患者的血浆成纤维细胞生长因子23水平与心率变异性
Osteoporos Int. 2015 Jan;26(1):395-405. doi: 10.1007/s00198-014-2862-7. Epub 2014 Sep 16.
9
A brief review and clinical application of heart rate variability biofeedback in sports, exercise, and rehabilitation medicine.心率变异性生物反馈在运动、锻炼和康复医学中的简要回顾及临床应用。
Phys Sportsmed. 2014 May;42(2):88-99. doi: 10.3810/psm.2014.05.2061.
10
Heart rate variability and the metabolic syndrome: a systematic review of the literature.心率变异性与代谢综合征:文献系统综述。
Diabetes Metab Res Rev. 2014 Nov;30(8):784-93. doi: 10.1002/dmrr.2555.